We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$2.85T
| $3.69B | 5.17% |
15,404,027
-2,523,342
| -14% | -$606M |
|
2
Apple
AAPL
$4.88T
| $1.35B | 1.88% |
10,364,251
+442,408
| +4% | +$63.2M |
|
3
Alphabet (Google) Class C
GOOG
$3.91T
| $1.15B | 1.61% |
12,975,422
-1,494,383
| -10% | -$143M |
|
|
4
Alphabet (Google) Class A
GOOGL
$3.92T
| $1.15B | 1.6% |
12,978,143
-1,004,110
| -7% | -$95.4M |
|
5
UnitedHealth
UNH
$382B
| $1.01B | 1.42% |
1,909,559
-531,832
| -22% | -$282M |
|
6
Merck
MRK
$324B
| $1.01B | 1.41% |
9,082,402
-779,907
| -8% | -$79.7M |
|
|
7
Oracle
ORCL
$341B
| $960M | 1.34% |
11,738,639
+2,963,412
| +34% | +$225M |
|
8
TSMC
TSM
$2.11T
| $923M | 1.29% |
12,390,924
-1,322,936
| -10% | -$95.7M |
|
9
BP
BP
$113B
| $894M | 1.25% |
25,593,846
-1,466,545
| -5% | -$48.8M |
|
10
Mastercard
MA
$472B
| $888M | 1.24% |
2,553,534
+634,198
| +33% | +$209M |
|
11
Union Pacific
UNP
$183B
| $814M | 1.14% |
3,929,921
-239,298
| -6% | -$49.1M |
|
12
IBM
IBM
$202B
| $778M | 1.09% |
5,519,602
+1,178,556
| +27% | +$163M |
|
|
13
Visa
V
$672B
| $733M | 1.03% |
3,528,365
+1,331,360
| +61% | +$268M |
|
14
Eli Lilly
LLY
$1.07T
| $707M | 0.99% |
1,933,216
-549,575
| -22% | -$195M |
|
15
Gilead Sciences
GILD
$161B
| $705M | 0.99% |
8,216,034
-3,820,541
| -32% | -$303M |
|
16
Suncor Energy
SU
$77.7B
| $703M | 0.98% |
22,165,045
+2,385,561
| +12% | +$78.4M |
|
|
17
Bank of America
BAC
$435B
| $692M | 0.97% |
20,878,814
-14,238,285
| -41% | -$490M |
|
18
Abbott
ABT
$180B
| $690M | 0.97% |
6,288,170
-338,186
| -5% | -$35M |
|
19
Medtronic
MDT
$106B
| $681M | 0.95% |
8,764,281
+1,602,609
| +22% | +$130M |
|
20
Comcast
CMCSA
$79.3B
| $673M | 0.94% |
19,240,269
+3,118,756
| +19% | +$103M |
|
21
Amazon
AMZN
$2.51T
| $654M | 0.92% |
7,786,622
-1,815,789
| -19% | -$179M |
|
22
Home Depot
HD
$329B
| $646M | 0.9% |
2,045,792
-288,721
| -12% | -$88M |
|
23
Automatic Data Processing
ADP
$99.1B
| $608M | 0.85% |
2,546,111
-5,116
| -0.2% | -$1.26M |
|
24
Adobe
ADBE
$88.5B
| $607M | 0.85% |
1,804,981
+392,404
| +28% | +$126M |
|
25
Procter & Gamble
PG
$342B
| $553M | 0.77% |
3,647,835
-1,993,299
| -35% | -$279M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.